BridgeBio Oncology Therapeutics Price Chart
BridgeBio Oncology Therapeutics Volume Chart
BridgeBio Oncology Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
+0.24(+3.24%)
| Open | $7.41 |
|---|---|
| Close | $7.65 |
| Low | $7.29 |
| Low Change | -0.12 (-1.62%) |
| High | $7.67 |
| High Change | +0.26 (+3.51%) |
| Range | $0.38 |
| Volume | 192.095K |
| Dollar Volume | $1.47M |
Premarket
+0.00(+0.00%)
| Open | $7.54 |
|---|---|
| Close | $7.54 |
| Low | $7.54 |
| Low Change | 0.00 (0.00%) |
| High | $7.54 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 200 |
| Dollar Volume | $1.51K |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.24(+3.24%)
| Open | $7.41 |
|---|---|
| Close | $7.65 |
| Low | $7.29 |
| Low Change | -0.12 (-1.62%) |
| High | $7.67 |
| High Change | +0.26 (+3.51%) |
| Range | $0.38 |
| Volume | 192.095K |
| Dollar Volume | $1.47M |
Premarket Yesterday
+0.00(+0.00%)
| Open | $7.54 |
|---|---|
| Close | $7.54 |
| Low | $7.54 |
| Low Change | 0.00 (0.00%) |
| High | $7.54 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 200 |
| Dollar Volume | $1.51K |
BridgeBio Oncology Therapeutics News
BridgeBio Oncology Therapeutics Top Trades
BridgeBio Oncology Therapeutics's top trade so far today returned +4.94%, while the top short trade returned -3.32%.
BridgeBio Oncology Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $7.53 |
|---|---|
| 10 Day Moving Average (SMA10) | $7.63 |
| 20 Day Moving Average (SMA20) | $7.72 |
| 50 Day Moving Average (SMA50) | $8.24 |
| 100 Day Moving Average (SMA100) | $8.98 |
| 200 Day Moving Average (SMA200) | $10.44 |
BridgeBio Oncology Therapeutics Statistics
| Average Volume (30 Days) | 495.53K |
|---|---|
| P/E Ratio (Current) | -4.74 |
| EPS (Current) | -$1.56 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$149.71M |
| Cash Ratio | 1.22 |
| Current Ratio | 6.16 |
| Quick Ratio | 6.16 |
| Debt to Equity | 0.00 |
| Enterprise Value | $540.85M |
| EV to EBITDA | -3.89 |
| EV to Sales | 466652.78 |
| Price to Book | 1.59 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 511469.00 |
| Return on Assets | -0.30% |
| Return on Equity | -0.34% |
BridgeBio Oncology Therapeutics Stock Splits
There have been no stock splits for BridgeBio Oncology Therapeutics (BBOT).
BridgeBio Oncology Therapeutics Dividends
There have been no dividends for BridgeBio Oncology Therapeutics (BBOT).